Swiss stocks - Factors to watch on August 24
24/08/2021 05:52
ZURICH/BERLIN, Aug 24 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Tuesday:
NOVARTIS NOVN.S
Novartis said its Kymriah to treat aggressive B-cell
non-Hodgkin lymphoma (NHL) after relapse or lack of response to
first-line treatment did not meet its primary endpoint of
event-free survival compared to treatment with the
standard-of-care in a phase III study.
For more, click on NOVN.S
COMPANY STATEMENTS
* Arbonia ARBNO.S said its group result after tax jumped
to 23.6 million Swiss francs in the first half of 2021 from 5.9
million. ARBNO.S
* BV Holding BVHN.BN said its reported consolidated EBITDA
amounted to CHF 12.3m in the first half after CHF 13.8m in the
prior year period. It has sold all investments except for a
majority stake in Skan Holding AG, which plans an Initial Public
Offering (IPO) at SIX Swiss Exchange in the fourth quarter of
2021. The shares of BV Holding AG will be delisted from BX Swiss
immediately before the IPO of the Skan Group at SIX Swiss
Exchange.
* Credit Suisse CSGN.S hired Emre Gunalp as global co-head
of diversified industrials investment banking, Bloomberg
reported late on Monday. CSGN.S
* Flughafen Zürich AG FHZN.S said it recorded a
consolidated loss of 45.1 million Swiss francs for the first
half year that was marked by pandemic-related travel
restrictions. FHZN.S
* Intershop ISN.S said net profit increased by 20% to CHF
40.9 million in the first half. ISN.S
* Landis+Gyr LANDI.S said it had signed a contract with
Louisville Gas and Electric Company and Kentucky Utilities
Company for advanced metering infrastructure and IOT network.
LANDI.S
* Leclanche LECN.S said it appointed Guillaume Clement as
vice president of its e-marine business and opened an office in
Oslo. LECN.S
* LLB Group LLBN.S said group net profit increased to 71.1
million Swiss francs in the first half of the year. LLBN.S
* Schindler SCHP.S said it won a contract to deliver and
install 180 escalators for two new routes of the Bangalore Metro
Rail Corporation Ltd. SCHP.S
* Vetropack VETN.S said its consolidated semi-annual
profit reached CHF 40.4 million. VETN.S
* Vifor Pharma VIFN.S announced with Cara Therapeutics
U.S. FDA approval of Korsuva injection for the treatment of
moderate-to-severe pruritus in hemodialysis patients. VIFN.S
ANALYSTS' VIEWS
ZURICH INSURANCE GROUP AG ZURN.S : JEFFERIES RAISES TARGET
PRICE TO CHF 395 FROM CHF 365
ECONOMY
No major Swiss economic data scheduled.
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))